Drug
Scopolamine patch
Scopolamine patch is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_4
2
67%
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (33.3%)
Phase 42 (66.7%)
Trials by Status
active_not_recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingphase_4
Multimodal Analgesia Effect on Post Surgical Patient
NCT04240626
completedearly_phase_1
The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression
NCT02849639
completedphase_4
Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section
NCT02960113
Clinical Trials (3)
Showing 3 of 3 trials
NCT04240626Phase 4
Multimodal Analgesia Effect on Post Surgical Patient
NCT02849639Early Phase 1
The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression
NCT02960113Phase 4
Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3